Prolonged treatment of porcine pulmonary artery with nitric oxide decreases cGMP sensitivity and cGMP-dependent protein kinase specific activity
Authors:
- William J. PerkinsWPWilliam J. Perkins
- Masahiro EnomotoMEMasahiro Enomoto
- Amish JainAJAmish Jain
- Jingyi PanJPJingyi Pan
- Yulia ShifrinYSYulia Shifrin
- Todd Van VlietTVTodd Van Vliet
- Patrick J. McNamaraPMPatrick J. McNamara
- Robert P. JankovRJRobert P. Jankov
- Jaques BelikJBJaques Belik
- Huijuan MaHMHuijuan Ma
- 1 January 2009
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 296 (1) , L121-L129
Abstract
A cultured porcine pulmonary artery (PA) model was used to examine the effects of prolonged nitric oxide (NO) treatment on the response to acutely applied NO, cGMP analog, or atrial natriuretic peptide (ANP). Twenty-four-hour treatment with the NO donor ( Z)-1-[ N-(2-aminoethyl)- N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate (DETA-NO) resulted in >10-fold decrease in the response to acutely applied DETA-NO. In parallel with this, the relaxant response to acutely applied cGMP analog, β-phenyl-1, N2-etheno-8-bromoguanosine-3′,5′-cyclic monophosphorothioate, Sp isomer (Sp-8-Br-PET-cGMPS), and ANP decreased. The reduction in ANP responsiveness in PA was not associated with a reduction in cGMP levels evoked by 10−6M ANP. Twenty-four hours in culture and treatment with DETA-NO decreased total cGMP-dependent protein kinase (cGKI) mRNA level compared with that in freshly prepared PA (1.05 ± 0.12, 0.42 ± 0.08, and 0.11 ± 0.01 amol/μg, respectively). Total cGKI protein levels were decreased to a lesser extent by 24 h in culture and further decreased by 24-h DETA-NO treatment compared with that in freshly prepared PA (361 ± 33, 272 ± 20, and 238 ± 25 ng/mg total protein, respectively). Maximal cGMP-stimulated phosphotransferase activity was reduced in 24-h cultured and DETA-NO-treated PA (986 ± 84, 815 ± 81, and 549 ± 78 pmol Pi·min−1·mg soluble protein−1), but the cGMP concentration resulting in 50% of maximal phosphotransferase activity was not. cGKI specific activity (maximal cGMP-activated phosphotransferase activity/ng cGKI) was significantly reduced in PA treated with DETA-NO for 24 h compared with freshly prepared and 24-h cultured PA (1.95 ± 0.22, 2.64 ± 0.25, and 2.85 ± 0.28 pmol Pi·min−1·ng cGKI−1, respectively). We conclude that prolonged NO treatment induces decreased acute NO responsiveness in PA in part by decreasing cGMP sensitivity. It does so by decreasing both cGKI expression and cGKI specific activity.Keywords
This publication has 54 references indexed in Scilit:
- Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylationProceedings of the National Academy of Sciences, 2007
- Glucose down-regulation of cGMP-dependent protein kinase I expression in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen speciesFree Radical Biology and Medicine, 2007
- Membrane guanylyl cyclase receptors: an updateTrends in Endocrinology & Metabolism, 2006
- The Biology of Cyclic GMP-dependent Protein KinasesJournal of Biological Chemistry, 2005
- Vascular natriuretic peptide receptor‐linked particulate guanylate cyclases are modulated by nitric oxide–cyclic GMP signallingBritish Journal of Pharmacology, 2003
- Direct activation of PDE5 by cGMPJournal of Cell Biology, 2003
- Enhanced Endothelium-Dependent Relaxations After Gene Transfer of Recombinant Endothelial Nitric Oxide Synthase to Rabbit Carotid ArteriesHypertension, 1997
- Regulation of the Expression of Cyclic GMP-Dependent Protein Kinase by Cell Density in Vascular Smooth Muscle CellsJournal of Vascular Research, 1994
- The activation of expressed cGMP‐dependent protein kinase isozymes Iα and Iβ is determined by the different amino‐terminiEuropean Journal of Biochemistry, 1991
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976